EBAMed Announces First Patient Enrolled in Prospective Imaging Study with Ultrasound Guidance Prototype in Ventricular Tachycardia Patients
EBAMed SA, an early-stage medical device company pioneering new approaches to proton therapy today announced the enrollment of the first patient in a prospective imaging study using a device that automatically interprets cardiac ultrasound images to uniquely track the motion of Mehr